Endovia Health Sciences (EDVA) Stock Price, Financials & Analysis

Key Stats

Market Cap477,205.70

P/E-0.03

P/S14.87

Div. Yield0.00

Total Debt (Qtr)6.00 Mn

Add ratio to table…

About

Splash Beverage Group, Inc. is a portfolio company that historically managed brands within the consumer beverage industry. The company currently focuses on the development and distribution of its Chispo Tequila brand while pursuing a potential acquisition of Medterra CBD a manufacturer of federally compliant cannabinoid wellness products. Its core activities involve sourcing producing and marketing beverage alcohol products and evaluating expansion into the wellness…

The company generates revenue primarily from the sale of Chispo Tequila through independent distributors and on premise hospitality accounts such as Senor Frog s. Revenue is recognized when product is shipped to distributors who then sell to retail and venue locations. In addition the company anticipates future revenue from the sale of cannabinoid wellness products contingent upon the completion of the Medterra acquisition. Historically revenue has been limited due to insufficient capital resources which prevented operations from February 2025 through March 2026.

The beverage alcohol industry is highly competitive with numerous international national regional and local producers and distributors. Competitive success depends on price promotional activity advertising marketing programs point of sale merchandising retail space management customer service product differentiation packaging innovation and distribution methods. Splash Beverage Group Inc seeks to differentiate its Chispo Tequila through an authentic blue agave blanco profile and its placement as the house tequila for Senor Frog s locations. If the Medterra acquisition is completed the company expects to gain a position in the growing cannabinoid wellness market where competition includes established CBD and hemp derived product makers.

The company serves on premise hospitality channels including restaurants bars and hotels with Senor Frog s being a named house tequila partner across locations in Florida the Bahamas and Mexico. It also supplies independent distributors who place the product in retail stores in the United States Guatemala and Europe. Should the Medterra transaction close the customer base would expand to include consumers of cannabinoid wellness products sold through wellness retailers and online channels.

How Endovia Health Sciences ranks

Ranked against the 41 companies in Beverages58 metrics · as of Oct 21, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last

P/ENegative earnings −0.02xMedian 28.1x 5^th
P/FCFNegative free cash flow −0.08xMedian 18.7x 3^rd
P/Operating cash flowNegative operating cash flow −0.08xMedian 13.0x 4^th
P/S 14.3xMedian 1.66x 5^th
P/BNegative shareholder equity −0.03xMedian 2.68x Not meaningful —
P/Tangible bookNegative tangible equity −0.03xMedian 3.50x Not meaningful —
EV/EBITDANegative EBITDA −0.49xMedian 13.8x 8^th
EV/EBITNegative EBIT −0.46xMedian 19.2x 7^th
EV/Revenue 194xMedian 1.89x 1^st
EV/FCFNegative free cash flow −1.13xMedian 20.9x 4^th
EV/Operating cash flowNegative operating cash flow −1.13xMedian 15.3x 4^th
PEG (3Y EPS CAGR)Negative earnings 0.00Median 2.13 Not meaningful —

Growth

14 metrics · Year-on-year growth and three-year compound annual growth

Revenue growth (1Y) 102%Median 10.6% 90^th
Revenue CAGR (3Y) −88.4%Median 4.3% 1^st
Gross profit growth (1Y) 105%Median 7.3% 90^th
Gross profit CAGR (3Y) −84.5%Median 5.1% 1^st
Operating income growth (1Y) −121%Median 13.0% 19^th
Operating income CAGR (3Y) 8.4%Median 10.4% 43^rd
Net income growth (1Y) 33.3%Median 16.4% 64^th
Net income CAGR (3Y) 3.6%Median 8.3% 32^nd
EPS growth (1Y) 88.9%Median 29.4% 84^th
EPS CAGR (3Y) −48.6%Median 16.5% 7^th
Operating cash flow growth (1Y) −11.3%Median 19.8% 15^th
Operating cash flow CAGR (3Y) 25.9%Median 13.8% 58^th
Free cash flow growth (1Y) −11.3%Median 13.0% 21^st
Free cash flow CAGR (3Y) 26.1%Median 14.6% 63^rd

Profitability

14 metrics · Margins, returns on capital and the quality of earnings

Gross margin 79.0%Median 40.8% 99^th
EBITDA margin <−10,000%Median 7.2% 1^st
Operating margin <−10,000%Median 1.1% 1^st
Pretax margin <−10,000%Median 2.1% 1^st
Net margin <−10,000%Median 0.0% 1^st
FCF margin <−10,000%Median 7.6% 1^st
Operating cash flow margin <−10,000%Median 12.2% 1^st
Return on equity —Median 5.1% No data —
Return on assets −1,728%Median 0.3% 1^st
Return on invested capital —Median 6.0% No data —
Return on capital employed —Median 3.9% No data —
Asset turnover 0.03xMedian 0.74x 3^rd
Cash conversion (OCF / net income)Net income is not positive 0.32xMedian 1.39x Not meaningful —
Stock comp / revenue >10,000%Median 1.1% 1^st

Financial Health

11 metrics · Leverage, liquidity and solvency; less debt ranks higher

Debt / assets 557%Median 34.6% 3^rd
Debt / equityNegative shareholder equity −0.38xMedian 0.63x Not meaningful —
Net debt / EBITDAEBITDA is not positive −0.45xMedian 2.52x Not meaningful —
Debt / FCFFree cash flow is not positive −1.09xMedian 4.53x Not meaningful —
Liabilities / assets 1,563%Median 60.4% 1^st
Equity / assetsNegative shareholder equity −1,463%Median 39.6% 1^st
Interest coverage −5.67xMedian 2.23x 24^th
Current ratio 0.05xMedian 1.36x 1^st
Quick ratio 0.02xMedian 0.72x 1^st
Cash ratio 0.01xMedian 0.41x 1^st
Altman Z-score −302Median 1.29 1^st

Shareholder Returns

7 metrics · Cash returned through dividends and buybacks; a lower payout ranks higher

Dividend yield —Median 2.7% No dividend —
Net buyback yieldAbove 100% of market value −783%Median 0.3% Not meaningful —
Shareholder yieldAbove 100% of market value −783%Median 2.0% Not meaningful —
Payout ratio (earnings) —Median 71.9% No dividend —
Payout ratio (FCF) —Median 46.1% No dividend —
Dividend growth (1Y) —Median 0.5% No dividend —
Dividend CAGR (3Y) —Median 3.9% No dividend —

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	KO	Coca Cola Co	399.08 Bn	27.88	7.96	43.50 Bn
2	KOF	Coca Cola Femsa Sab De Cv	198.07 Bn	148.87	11.98	-
3	PEP	Pepsico Inc	183.70 Bn	16.86	1.87	51.88 Bn
4	MNST	Monster Beverage Corp	91.30 Bn	42.91	9.90	-
5	DEO	Diageo Plc	51.63 Bn	29.90	2.05	22.80 Bn
6	ABEV	Ambev S.A.	51.46 Bn	16.39	3.09	1.11 Bn
7	CCEP	COCA-COLA EUROPACIFIC PARTNERS plc	50.42 Bn	23.57	2.16	12.56 Bn
8	EDVA	Endovia Health Sciences, Inc.	0.00 Bn	-0.03	14.87	0.01 Bn

S.No.

Ticker

Company

Market Cap

P/E

P/S

Total Debt (Qtr)

Coca Cola Co

399.08 Bn

27.88

7.96

43.50 Bn

KOF

Coca Cola Femsa Sab De Cv

198.07 Bn

148.87

11.98

PEP

Pepsico Inc

183.70 Bn

16.86

1.87

51.88 Bn

MNST

Monster Beverage Corp

91.30 Bn

42.91

9.90

DEO

Diageo Plc

51.63 Bn

29.90

2.05

22.80 Bn

ABEV

Ambev S.A.

51.46 Bn

16.39

3.09

1.11 Bn

CCEP

COCA-COLA EUROPACIFIC PARTNERS plc

50.42 Bn

23.57

2.16

12.56 Bn

EDVA

Endovia Health Sciences, Inc.

0.00 Bn

-0.03

14.87

0.01 Bn

Endovia Health Sciences EDVA

About

How Endovia Health Sciences ranks

Valuation

Growth

Profitability

Financial Health

Shareholder Returns

Peer Comparison

Endovia Health Sciences EDVA

About

How Endovia Health Sciences ranks

Valuation

Growth

Profitability

Financial Health

Shareholder Returns

Peer Comparison

Create an account

Sign In

Reset Password